Abstract
The burden of bacterial resistance was assessed for the first time in Russia. The analysis was based on the results of bacteriological studies in multi-field hospitals provided by the St. Petersburg Medical Information and analytical Center. The number of patients with infections caused by strains of methicillin-resistant S. aureus (MRSA); K. pneumoniae, are not sensitive to 3rd generation cephalosporins and carbapenems; E. coli, are not sensitive to 3rd generation cephalosporins was calculated on the basis of the obtained data. The data are extrapolated to all multi-profile hospitals of the Russian Federation with regard to known levels of resistance. The total cost of treatment of patients with infections caused by three pathogens in multi-field hospitals in St. Petersburg for the year amounted to 250 887 292 rubles, in Russia – 12 413 309 939 rubles. The main costs are associated with antimicrobial therapy (90% in St. Petersburg, 88 – in Russia). The costs associated with additional beds, temporary disability, epidemiological control measures are 10% and 12%, respectively. Mathematical modeling has shown that these costs can increase by at least 10% due to the death of patients of working age.
Pavlov First Saint-Petersburg State Medical University, St. Petersburg, Russia
St. George the Martyr City Hospital, St. Petersburg, Russia
Medical Information and Analysis Center, St. Petersburg, Russia
North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russia
Pavlov First Saint-Petersburg State Medical University, St. Petersburg, Russia
Saint-Petersburg State University, St. Petersburg, Russia
Children Scientific Clinical Center of Infectious Diseases, St. Petersburg, Russia
North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russia
Medical Information and Analysis Center, St. Petersburg, Russia
North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russia
North-Western State Medical University named after I.I. Mechnikov, St. Petersburg, Russia
Pavlov First Saint-Petersburg State Medical University, St. Petersburg, Russia
St. George the Martyr City Hospital, St. Petersburg, Russia
Saint-Petersburg State University, St. Petersburg, Russia
St. George the Martyr City Hospital, St. Petersburg, Russia
Saint-Petersburg State University, St. Petersburg, Russia
-
1.
Naylor N.R., Sachin S., Kavian K., et al. Methods for estimating the burden of antimicrobial resistance: a systematic literature review protocol. Syst Rev. 2016;5:187-191.
-
2.
Review on antimicrobial resistance, “Antimicrobial resistance: tackling a crisis for the health and wealth of nations”. Available: https://amr-review.org/Publications. Accessed 5 Feb 2015. World Health Organization. Global report on surveillance. Geneva: World Health Organization; 2014.
-
3.
Kozlov R.S. Resistance to antibiotics as a main issue of modern healthcare. Vestnik Roszdravnadzora. 2017;4:28-33. Russian.
-
4.
Kozlov R.S. Resistance to antimicrobials as a real threat of national security. Russkij medicinskij zhurnal. 2014;4:321-324. Russian.
-
5.
Berger M.L., Bingefors K., Hedblom E.C., et al. Torrance Health care cost, quality and outcomes. ISPOR book of terms. Torrance. Lawrenceville, NJ: ISPOR, 2003.
-
6.
Byford S., Torgerson D.J., Raftery J. Economic note: cost of illness studies. BMJ. 2000;320(7245):1335.
-
7.
Reuter P. What drug policies cost: estimating government drug policy expenditures. Addiction. 2006;101(3):315-322.
-
8.
Omelyanovsky V.V., Avksenyeva M.V., Derkach E.V., et al. Cost of illness analysis: issues and its solutions. Pediatricheskaja farmakologija. 2011;8(3):6-12. Russian.
-
9.
Larg A., Moss J.R. Cost-of-illness studies: a guide to critical evaluation. Pharmacoeconomics. 2011;29(8):653-671.
-
10.
Pechere J.C., Lacey L. Optimizing economic outcomes in antibiotic therapy of patients with acute bacterial exacerbations of chronic bronchitis. J Antimicrob Chemother. 2000;45:19-24.
-
11.
Kollef M.H., Fraser V.J. Antibiotic resistance in the intensive care unit. Ann Intern Med. 2001;134:298-314.
-
12.
Grossman R.F. Cost-effective therapy for acute exacerbations of chronic bronchitis. Semin Respir Infect. 2000;15:71-81.
-
13.
Grossman R.F. The value of antibiotics and the outcomes of antibiotic therapy in exacerbations of COPD. Chest. 1998;113:249S-255S.
-
14.
Forrest A., Nix D.E., Ballow C.H., et al. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother. 1993;37:1073-1081.
-
15.
Thomas J.K., Forrest A., Bhavnani S.M., et al. Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy. Antimicrob Agents Chemother. 1998;42:521-527.
-
16.
de Kraker M.E., Wolkewitz M., Davey P.G., et al. Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother. 2011;55:1598-1605.
-
17.
Barnett A.G., Beyersmann J., Allignol A., et al. The time-dependent bias and its effect on extra length of stay due to nosocomial infection. Value Health. 2011;14:381-386.
-
18.
Lambert M.L., Suetens C., Savey A., et al. Clinical outcomes of healthcare-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis. 2011;11:30-38.
-
19.
Report of the ASM task force on antibiotic resistance. Antimicrob Agents Chemother. 1995;Suppl:1-23.
-
20.
Phelps C.E. Bug/drug resistance. Sometimes less is more. Med Care. 1989;27:194-203.
-
21.
Rello J., Torres A., Ricart M., et al. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillinresistant and methicillin-sensitive episodes. Am J Respir Crit Care Med.1994;150:1545-1549.
-
22.
Pujol M., Corbella X., Pena C., et al. Clinical and epidemiological findings in mechanically ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia. Eur J Clin Microbiol Infect Dis. 1998;17:622-628.
-
23.
Gonzalez C., Rubio M., Romero-Vivas J. Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis. 1999;29:1171-1177.
-
24.
Leistner R., Gürntke S., Sakellariou C., et al. Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae and E. coli: an analysis of the disease burden in a large cohort. Infection. 2014;42:991-997.
-
25.
Stewardson A., Fankhauser C., De Angelis G., et al. Burden of bloodstream infection caused by extended-spectrum β-lactamaseproducing Enterobacteriaceae determined using multistate modeling at a Swiss University Hospital and a nationwide predictive model. Infect Control Hosp Epidemiol. 2013;34:133-143.
-
26.
Branch-Elliman W., Lee G.M., Golen T.H., et al. Health and Economic Burden of Post-Partum Staphylococcus aureus Breast Abscess. PLoS One. 2013;8:1-7.
-
27.
Nelson R.E., Samore M.H., Jones M., et al. Reducing Time-dependent Bias in Estimates of the Attributable Cost of Health Care-associated Methicillin-resistant Staphylococcus aureus Infections: A Comparison of Three Estimation Strategies. Med Care. 2015;53:827-834.
-
28.
World Health Organisation. Global report on surveillance. Geneva: World Health Organisation; 2014. URL: www.who.int/drugresistance/documents/surveillancereport/en/.
-
29.
Tillotson G.S., Zinner S.H. Burden of antimicrobial resistance in an era of decreasing susceptibility. Expert Rev Anti Infect Ther. 2017;15:663-676.
-
30.
Kuzmenkov A.Yu, Trushin I.V, Avramenko A.A., et al. AMRmap: an online platform for monitoring antibiotic resistance. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2017;19(2):84-90. Russian.
-
31.
Healthcare in Russia. 2017. Moscow: Rosstat; 2017. 170 p. Russian.
-
32.
Work results in sphere of healthcare of St.Petersburg in 2015 and main goals in 2016. St.Petersburg: SPb GBUZ MIAC; 2016. 358 p. Russian
-
33.
Price list of Scientific Institution of Emergency Healthcare. URL: www.emergency.spb.ru/services/paid. Russian
-
34.
General tariff agreement 2018. URL: https://spboms.ru/page/docs. Russian.
-
35.
Federal low dated 29.12.2006 #255-FZ “About obligatory social insurance in case of temporary disability and in connection with motherhood”. Russian.
-
36.
Federal agency of state statistics. URL: www.gks.ru. Russian.
-
37.
Resolution of the Chief state sanitary doctor of the Russian Federation of May 18, 2010 №58 “on approval of SanPiN 2.1.3.262010 “Sanitary and epidemiological requirements for organizations engaged in medical activities.” http://base.garant.ru/12177989/. Russian.
-
38.
Epidemiology and epidemiological monitoring of infections caused by methicillin-resistant strains of Staphylococcus aureus. Federal clinical guidelines. Мoscow; 2014. 50 p. Russian.
-
39.
The price list for paid services (works) rendered to FBUZ “Center of hygiene and epidemiology in Saint Petersburg” and it’s Subsidiaries on 05.07.2018. https://78centr.ru/. Russian.
-
40.
SNiP II-L. 9-70 Hospitals and clinics. Design standards. APPROVED by the state Committee of the Council of Ministers of the USSR for construction on December 31, 1970. http://docs.cntd.ru/document/1200065278. Russian.
-
41.
Register of maximum permissible prices. www.grls.rosminzdrav.ru. Russian.
-
42.
Sidorenko S.V., Кolbin А.S., Shlyapnikov S.А., et al. Pharmacoepidemiological study of the use of antibacterial agents in multidisciplinary hospitals of St. Petersburg. Antibiotiki i himioterapija. 2017;62(7-8):17-24. Russian.
-
43.
Cosgrove S.E., Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis. 2003;36:14331437.
-
44.
Smith R., Coast J. The true cost of antimicrobial resistance. BMJ. 2013;346:f1493.
-
45.
Gomon Y.M., Kolbin A.S. Analysis of effectiveness criteria during pharmacoeconomic studies of antibacterial drugs (data from limited lists of Russian Federation 2014-2016). Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2017;19(3):260-264. Russian.